Pancreatic Cancer Research

ResearcherThe Wistar InstituteActive in the last 2 years

Gauri Mirji

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6439-8204; OpenAlex author ID A5014036225. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Targeting Interactions Between Siglec-10 and α3β1 Integrin Enhances Macrophage-Mediated Phagocytosis of Pancreatic Cancer. First author DOI 10.1158/0008-5472.can-25-0977↗
  2. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Co-author DOI 10.1126/sciimmunol.abn0704↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rahul Suresh Shinde · 2 shared papers, 2022–2026 · strength 0.38
  2. Mohamed Abdel‐Mohsen · 2 shared papers, 2022–2026 · strength 0.38
  3. Pratima Saini · 1 shared paper, 2026 · strength 0.25
  4. Hiroaki Tateno · 1 shared paper, 2026 · strength 0.25
  5. Ben Z. Stanger · 1 shared paper, 2022 · strength 0.13
  6. Chi Van Dang · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.